Growth in this market will largely be driven by increasing demand for mAbs, increasing R&D expenditure by pharmaceutical and biopharmaceutical companies, and growing focus on proteomic and genomic research.
[119 Pages Report] The global desalting and buffer exchange market is projected to reach USD 1,094.8 million by 2023 from USD 679.8 million in 2018, at a CAGR of 10.0%. The base year considered for the study is 2017, and the market forecast is provided for 2018–2023.
Desalting and Buffer Exchange Market: Research Methodology
Both, top-down and bottom-up approaches were used to validate the size of the global market and estimate the size of various other dependent submarkets. Major players in the market were identified through secondary research and their market presence was studied through primary and secondary research. Secondary research included the study of the annual and financial reports of top market players, presentations, websites, and press releases of top players, news articles, journals; and paid databases ,white papers, medical journals, certified publications, articles from recognized authors, directories, and databases such as Clinical Proteomic Tumor Analysis Consortium (CPTAC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), US FDA, Chromatographic Society (ChromSoc), European Society for Separation Science. Whereas, primary research included extensive interviews with key opinion leaders such as CEOs, vice presidents, directors, marketing executives, and related key executives from various companies. The percentage splits, shares, and breakdowns of the segments were determined using secondary sources and verified through primary sources. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=3721738
Based on product, the kits segment is expected to account for the largest share of the market in 2018
On the basis of product, the market is broadly segmented into kits, cassettes & cartridges, spin columns, filter plates, membrane filters, and other consumables and accessories. The kits segment is expected to account for the largest share of the global desalting and buffer exchange market in 2018 and is projected to register the highest CAGR during the forecast period. The large share of this segment is primarily attributed to the increasing use of desalting kits for analytical sample preparation for SDS-PAGE and mass spectrometry, as well as downstream purification.
Based on technique, the filtration segment is expected to account for the largest share of the market in 2018
On the basis of technique, the market is broadly segmented into filtration, chromatography, and precipitation. The filtration market is further segmented into ultrafiltration and dialysis techniques. The chromatography market is further segmented into size exclusion chromatography and other chromatography techniques. The filtration segment is expected to account for the largest share of the global desalting and buffer exchange market in 2018. The large share of this segment is attributed to the increased production of biologics and growth of proteomics and genomics research.
Based on application, the bioprocess segment is expected to account for the largest share of the market in 2018
On the basis of application, the market is broadly segmented into bioprocess and diagnostics. The bioprocess application segment is expected to account for the largest share of the global desalting and buffer exchange market in 2018. The large share of this segment is attributed to the growing demand for biopharmaceuticals and monoclonal antibodies, as well as increasing R&D expenditure by biopharmaceutical companies.
North America is expected to dominate the market in 2018
In 2018, North America is expected to account for the largest share of the global desalting and buffer exchange market. The large share of this regional segment is attributed to the increasing demand for biopharmaceuticals, rising R&D expenditure by biopharmaceutical companies, and growing research activities in the field of genomics and proteomics.
Key players in the global desalting and buffer exchange market are Thermo Fisher Scientific (US), Merck (US), GE Healthcare (US), Danaher (US), and Sartorius (Germany).
Request For Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=3721738
Key Market Players
Key players in the global desalting and buffer exchange industry are Thermo Fisher Scientific (US), Merck (US), GE Healthcare (US), Danaher (US), and Sartorius (Germany).
